Floatz logo

71 assets in Primary Central Nervous System Lymphoma

Therapeutic assets addressing Primary Central Nervous System Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Etoposide
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BBB (73)
(+)-Vincristine
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P4BBB (72)
Adriamycin
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MDP4BB (70)
Idarubicin
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (70)
Orelabrutinib
Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP3BB (70)
Cyclophosphamide
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MDP4BB (69)
Cytarabine
Primary Central Nervous System Lymphoma
The Lymphoma Academic Research OrganisationP4BB (69)
Dexasone
Primary Central Nervous System Lymphoma
Allison WinterP4BB (69)
Rituximab
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P4BB (69)
Methotrexate
Primary Central Nervous System Lymphoma
Assistance Publique Hopitaux De MarseilleP4BB (68)
Ibrutinib
Primary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer CenterP2BB (67)
Lomustine
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (66)
Procarbazine
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P3BB (66)
Tirabrutinib
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P3BB (66)
Isocyclophosphamide
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (65)
Lenalidomide
Primary Central Nervous System Lymphoma
NOBO MedicineP2BB (65)
Nivolumab
Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (65)
Camustine
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (64)
Melphalan
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4B (63)
Thiotepa
Primary Central Nervous System Lymphoma
Zhejiang Cancer HospitalP2B (63)
Acalabrutinib
Primary Central Nervous System Lymphoma
Jonsson Comprehensive Cancer CenterP2B (62)
Pembrolizumab
Primary Central Nervous System Lymphoma
Dana-Farber Cancer InstituteP2B (62)
Prednisone
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MDP2B (62)
Bendamustine
Primary Central Nervous System Lymphoma
Miltenyi Biomedicine GmbHP2B (60)
Busulfanum
Primary Central Nervous System Lymphoma
Sichuan UniversityP2/3B (60)
Durvalumab
Primary Central Nervous System Lymphoma
Washington University School of MedicineP2B (60)
Epcoritamab
Primary Central Nervous System Lymphoma
The Lymphoma Academic Research OrganisationP2B (60)
Fludarabine
Primary Central Nervous System Lymphoma
City of Hope Medical CenterP2B (60)
Pomalidomide
Primary Central Nervous System Lymphoma
Beijing Tongren HospitalP2B (60)
Isavuconazole
Primary Central Nervous System Lymphoma
National Cancer Institute (NCI)P2B (58)
Obinutuzumab
Primary Central Nervous System Lymphoma
City of Hope Medical CenterP2B (58)
Selinexor
Primary Central Nervous System Lymphoma
Ruijin HospitalP2B (58)
Zanubrutinib
Primary Central Nervous System Lymphoma
Ruijin HospitalP2B (58)
Rvp-001
Primary Central Nervous System Lymphoma
Reveal Pharmaceuticals Inc.P2B (57)
Teniposide
Primary Central Nervous System Lymphoma
Huashan HospitalP2/3CCC (55)
Anbalcabtagene Autoleucel
Primary Central Nervous System Lymphoma
Hyungwoo ChoP2CCC (53)
Boclatixafortide
Primary Central Nervous System Lymphoma
Pentixapharm AGP2CCC (53)
Decitabine
Primary Central Nervous System Lymphoma
Chinese PLA General HospitalP2CCC (53)
Iopofosine (¹³¹I)
Primary Central Nervous System Lymphoma
Cellectar Biosciences, Inc.P2CCC (53)
Paxalisib
Primary Central Nervous System Lymphoma
Lakshmi Nayak, MDP2CCC (53)
Penpulimab
Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (53)
Pirtobrutinib
Primary Central Nervous System Lymphoma
Zhejiang Cancer HospitalP2CCC (53)
R-Pmdt
Primary Central Nervous System Lymphoma
Zou DehuiP2CCC (53)
Zamtocabtagene Autoleucel
Primary Central Nervous System Lymphoma
Miltenyi Biomedicine GmbHP2CCC (53)
Emavusertib
Primary Central Nervous System Lymphoma
Curis, Inc.P1/2CCC (48)
Pteroylmonoglutamic Acid Hydrolase G2
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de ParisP1CC (46)
(90Y)-PENTIXATHER
Primary Central Nervous System Lymphoma
Pentixapharm AGP1/2CC (45)
cd22 car-transduced t cells
Primary Central Nervous System Lymphoma
Essen BiotechP1/2CC (45)
eb103
Primary Central Nervous System Lymphoma
Estrella Biopharma, Inc.P1/2CC (45)
Gnc-038
Primary Central Nervous System Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.P1/2CC (45)
Showing 1 to 50 of 71 assets
PreviousPage 1 of 2Next